Showing articles with keyword: IU School of Medicine | CLEAR
June 27, 2018
Research by CTSI-Supported Investigator Has Led to First-in-Human Clinical Trial
Milan Radovich, PhD
Early research by Indiana University School of Medicine’s Milan Radovich, PhD, whose work was supported by the Indiana CTSI, has led to the launch of a first-in-human clinical trial that aims to treat an aggressive type of breast cancer.
Dr. Radovich, who is now an assistant professor in the IU School of Medicine’s Department of Surgery, received a Pre-doctoral (TL1) Award from the Indiana CTSI in 2010-2011 for his research project titled “Novel targets in triple negative breast cancer.”
He says that research has informed the clinical trial going on now, which is using precision medicine to target multiple genetic culprits...
June 21, 2018
CTSI Kicks Off Summer Research Program for Area High School Students
By Ashlynnn Neumeyer:
Summer is here and that means we again welcome central Indiana high school students to research labs in Indianapolis for the Indiana Clinical and Translational Sciences Institute’s (CTSI) Project STEM summer research program, which includes Indianapolis Project STEM, Indianapolis Project SEED and the Future Scientists Program.
2018 Project STEM program staff, participants, and their families at a recent kick-off meeting. (Andrea Zeek/Indiana CTSI photo)
This year, the program is celebrating the 50th anniversary of the American Chemical Society starting the national Project SEED program in 1968, and the 45th anniversary of the beginning of the Indianapolis program at IU...
May 21, 2018
Three Decades of Research Culminates in FDA Drug Approval
By IU School of Medicine and CTSI Staff Reports:
Indiana CTSI-supported research led by two Indiana University School of Medicine faculty members has culminated in U.S. Food and Drug Administration approval of a new drug for patients with an uncommon, painful and deforming bone disease.
IU School of Medicine researchers Michael Econs and Kenneth White (Photo courtesy of Indiana University)
The drug, burosumab, treats X-linked hypophosphatemia, or XLH. It is being brought to market by Ultragenyx Pharmaceutical Inc. in collaboration with Kyowa Hakko Kirin Co., Ltd. and its European subsidiary, Kyowa Kirin International PLC, under the brand name Crysvita.
XLH is a phosphate-wasting disease that...
May 11, 2018
IU Researchers Using CTSI 3D Bioprinting Core to Study Organs
Indiana University School of Medicine scientist and transplant surgeon Burcin Ekser, MD, PhD, will boost his lab’s xenotransplantation, or cross-species transplantation, research program with a four-year, $9 million research agreement with Lung Biotechnology PBC.
IU School of Medicine researchers Lester Smith, PhD; Burcin Ekser, MD, PhD; and Ping Li, PhD. (Photo courtesy of IU School of Medicine)
According to the latest data from the Organ Procurement and Transplantation Network, there are more than 110,000 people in the United States waiting for a life-saving organ transplant, and each day, about 20 people die while waiting for a transplant.
Dr. Ekser and his team are working...
August 23, 2017
IU Medical Students Awarded Scholarships for Research Presentations
Eleven second-year IU medical students have received scholarship awards through the Indiana Medical Student Program for Research and Scholarship (IMPRS), a collaboration of IU School of Medicine and the Indiana CTSI.
The students, who all participated in the IMPRS summer internship program, were first selected from a research poster session including 105 presenters. Then, 21 finalists were selected to give oral presentations to a panel of judges, including IU School of Medicine’s Janice Blum, PhD; Rebecca Chan, MD, PhD; Reubin Kapur, PhD; Peter J. Roach, PhD; and Timothy Sutton, MD, PhD. The scholarship money will go toward the students’ tuition.
February 16, 2017
Indiana CTSI leaders named Indiana University distinguished professors
Anantha Shekhar, MD, PhD
Nine Indiana University scholars and researchers have been promoted to distinguished professor, the highest academic rank the university bestows upon faculty.
The new distinguished professors include Indiana CTSI director Anantha Shekhar, MD, PhD, a neuroscientist and medical researcher in the IU School of Medicine, and Tatiana Foroud, PhD, scientific director of the Indiana Biobank and a statistical geneticist in the IU School of Medicine Department of Medical and Molecular Genetics.
“These acclaimed men and women represent the pinnacle of public education through their remarkable research, teaching and service in an extraordinarily wide range of disciplines,” IU President Michael A....